Synthesis and pharmacological evaluation of 6-aminonicotinic acid analogues as novel γ-aminobutyric acidA receptor agonists
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Synthesis and pharmacological evaluation of 6-aminonicotinic acid analogues as novel γ-aminobutyric acidA receptor agonists. / Petersen, Jette Gellert; Sørensen, Troels Ersted; Damgaard, Maria; Nielsen, Birgitte; Jensen, Anders A.; Balle, Thomas; Bergmann, Rikke; Frølund, Bente.
In: European Journal of Medicinal Chemistry, Vol. 84, 2014, p. 404-416.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Synthesis and pharmacological evaluation of 6-aminonicotinic acid analogues as novel γ-aminobutyric acidA receptor agonists
AU - Petersen, Jette Gellert
AU - Sørensen, Troels Ersted
AU - Damgaard, Maria
AU - Nielsen, Birgitte
AU - Jensen, Anders A.
AU - Balle, Thomas
AU - Bergmann, Rikke
AU - Frølund, Bente
PY - 2014
Y1 - 2014
N2 - A series of 6-aminonicotinic acid analogues have been synthesized and pharmacologically characterized at native and selected recombinant GABAA receptors. 6-Aminonicotinic acid (3) as well as 2- and 4-alkylated analogues (9–11, 14–16) display low to mid-micromolar GABAAR binding affinities to native GABAA receptors (Ki 1.1–24 μM). The tetrahydropyridine analogue of 3 (22) shows low-nanomolar affinity (Ki 0.044 μM) and equipotency as an agonist to GABA itself as well as the standard GABAA agonist isoguvacine. Cavities surrounding the core of the GABA binding pocket were predicted by molecular interaction field calculations and docking studies in a α1β2γ2 GABAA receptor homology model, and were confirmed by affinities of substituted analogues of 3. The tight steric requirements observed for the remarkably few GABAAR agonists reported to date is challenged by our findings. New openings for agonist design are proposed which potentially could facilitate the exploration of different pharmacological profiles within the GABAAR area.
AB - A series of 6-aminonicotinic acid analogues have been synthesized and pharmacologically characterized at native and selected recombinant GABAA receptors. 6-Aminonicotinic acid (3) as well as 2- and 4-alkylated analogues (9–11, 14–16) display low to mid-micromolar GABAAR binding affinities to native GABAA receptors (Ki 1.1–24 μM). The tetrahydropyridine analogue of 3 (22) shows low-nanomolar affinity (Ki 0.044 μM) and equipotency as an agonist to GABA itself as well as the standard GABAA agonist isoguvacine. Cavities surrounding the core of the GABA binding pocket were predicted by molecular interaction field calculations and docking studies in a α1β2γ2 GABAA receptor homology model, and were confirmed by affinities of substituted analogues of 3. The tight steric requirements observed for the remarkably few GABAAR agonists reported to date is challenged by our findings. New openings for agonist design are proposed which potentially could facilitate the exploration of different pharmacological profiles within the GABAAR area.
U2 - 10.1016/j.ejmech.2014.07.039
DO - 10.1016/j.ejmech.2014.07.039
M3 - Journal article
C2 - 25038482
VL - 84
SP - 404
EP - 416
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
SN - 0223-5234
ER -
ID: 118590454